Nachrichten - Pressemitteilungen

    Shire plc announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in …

    Themen: CapUSASom

    LEXINGTON, Massachusetts, January 30, 2015 /PRNewswire/ - Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII), the first and only …

    Wertpapier: Shire Sp ADR

    Themen: CapNASDAQSom
    ZeitTitel
    00:00 
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.
    30.01.

    Weitere Nachrichten Pressemitteilungen

    TitelLeser
    371
    342
    336
    282
    276
    271
    262
    261
    259
    245
    TitelLeser
    2252
    1633
    1471
    762
    678
    577
    561
    555
    551
    512
    TitelLeser
    3475
    3002
    2252
    1872
    1633
    1594
    1471
    1393
    1353
    1332
    TitelLeser
    88607
    18041
    17228
    14739
    13551
    11262
    10464
    10345
    10116
    9965